Cannabis Law Report
MARCH 9, 2019
In the case of CBD, this includes extracts, oils and other derived products that are intended for ingestion by humans. They are taking issue with the change by the EU in its submission for the term ‘cannabinoids’ states: “Extracts of Cannabis sativa L.
The Joint Blog
NOVEMBER 2, 2020
Methods: A systematic review by literature search through PubMed and EBSCO electronic databases was conducted for relevant studies reported after 2002 on the effects of medical marijuana or cannabis use on tremor, spasm, spasticity, chorea, sleep quality and HD-specific rating scales.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
OCTOBER 12, 2021
d/b/a Venom Extracts (“ Venom Extracts “) which transformed the Company into a multi-state operator and substantially enhanced its revenue, capabilities and reach. Jake is the founder of Venom Extracts, one of the industry’s premier award-winning cannabis concentrate brands. I’m humbled and excited to take on this challenge.
Cannabis Law Report
NOVEMBER 24, 2021
At the same time, the outlook on cannabis research data is largely positive. Politicians, policymakers, and legislators are important audiences who are influenced and, of course, specifically targeted by medical journals (Stryker 2002 ). Data collection. This offers a more denotative approach to complement the data.
Cannabis Law Report
JULY 12, 2019
However, there are indications from studies done with cannabidiol-rich cannabis extracts in Israel that indicate that less side effects (46%) are achieved with a natural cannabis plant extract containing a 20:1 ratio of CBD to THC. The CBD-rich extract group had a lower effective dose on average, 6.1
Green Relief
MAY 13, 2018
As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. In 2002, the Journal of Neuroscience reported that the impact of induced cerebral ischemia is much more severe in CB1 knockout mice than in “wild type” mice with cannabinoid receptors.
Green Relief
MAY 12, 2018
As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. In 2002, the Journal of Neuroscience reported that the impact of induced cerebral ischemia is much more severe in CB1 knockout mice than in “wild type” mice with cannabinoid receptors.
Expert insights. Personalized for you.
87 
Let's personalize your content